Nearly four times as many sufferers with liver-restricted, unresectable metastatic RAS-definite colorectal cancer (CRC) converted to resectable express when bevacizumab (Avastin) became added to chemotherapy,…
Nearly four times as many sufferers with liver-restricted, unresectable metastatic RAS-definite colorectal cancer (CRC) converted to resectable express when bevacizumab (Avastin) became added to chemotherapy,…